Ixsys, Inc.
Records under this name other than patents Ixsys, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,893,845 | Surface expression libraries of heteromeric receptors Formerly held Term ended Term ended May 17, 2022 · From the USPTO record | Term ended | Term ended May 17, 2022 | From the USPTO record |
| US 6,849,425 | Methods of optimizing antibody variable region binding affinity Term ended Term ended Nov 4, 2019 · From the USPTO record | Term ended | Term ended Nov 4, 2019 | From the USPTO record |
| US 6,531,580 | Anti-&agr;v&bgr;3 recombinant human antibodies and nucleic acids encoding same Formerly held Term ended Term ended Jun 24, 2019 · From the USPTO record | Term ended | Term ended Jun 24, 2019 | From the USPTO record |
| US 6,312,693 | Antibodies against human CD40 Formerly held Term ended Term ended Feb 10, 2019 · From the USPTO record | Term ended | Term ended Feb 10, 2019 | From the USPTO record |
| US 6,027,933 | Surface expression libraries of heteromeric receptors Term ended Term ended Feb 22, 2017 · From the USPTO record | Term ended | Term ended Feb 22, 2017 | From the USPTO record |
| US 6,348,194 | Tumor specific internalizing antigens and methods for targeting therapeutic agents Term ended Term ended Nov 13, 2015 · From the USPTO record | Term ended | Term ended Nov 13, 2015 | From the USPTO record |
| US 6,596,850 | Anti-&agr;v3&bgr;3 recombinant human antibodies, nucleic acids encoding same Lapsed on the fee record Ended Jul 22, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 22, 2015 | From the USPTO record |
| US 6,590,079 | Anti-&agr;v&bgr;3 recombinant human antibodies, nucleic acids encoding same Lapsed on the fee record Ended Jul 8, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 8, 2015 | From the USPTO record |
| US 6,258,530 | Surface expression libraries of randomized peptides Lapsed on the fee record Ended Jul 10, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jul 10, 2013 | From the USPTO record |
| US 7,422,744 | Methods of Treating Cancer with ALPHAVBETA3-SPECIFIC Antibodies Formerly held Lapsed on the fee record Ended Sep 9, 2012 · Medium confidence | Lapsed on the fee record | Ended Sep 9, 2012 | Medium confidence |